Ceva Santé Animale
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Ceva Santé Animale - overview
Established
1999
Location
Libourne, -, France
Primary Industry
Pharmaceuticals
About
Based in Libourne, France, and founded in 1999, Ceva Sante Animale operates as a global veterinary health company that researches, develops, produces, and markets vaccines and other pharmaceutical products for swine, poultry, livestock, and companion animals. In February 2020, a consortium led by Temasek Holdings, along with Continental Grain Company, Merieux Equity Partners, EMZ Partners, Hopu Investment Management, Mitsui & Corporation, Sagard Private Equity, Sofiproteol SA, and Tethys Invest, agreed to invest in CEVA Sante Animale. The company provides pet owners with safe and effective solutions for pet skin care and skin problems created in consultation with pet parents. Ceva provides veterinarians with a comprehensive set of educational tools on approaches to stress in dogs and cats.
The company helps protect pets against the spread of vector-borne diseases such as Lyme disease, heartworm, leishmaniasis, and more. In addition, the firm offers smart farming solutions that integrate equipment and devices, data solutions, and digital tools to adapt to all different customer conditions while respecting animal welfare best practices.
Current Investors
EMZ Partners, Nixen Partners, Natixis Investissement
Primary Industry
Pharmaceuticals
Sub Industries
Pet Products, Pharmaceutical Research & Development, Specialty Pharmaceuticals, Farm Equipment
Website
www.ceva.com
Verticals
Agtech
Company Stage
Mature
Total Amount Raised
Subscriber access only
Ceva Santé Animale - timeline of key events
Ceva Santé Animale - financials
| Fiscal Year Ended | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 373,066,000 | 439,474,000 | 533,085,000 | 576,005,000 | 622,404,000 | 663,173,000 | 756,515,000 | - | - | - |
| % Revenue Growth (YoY) | - | 17.8% | 21.3% | 8.1% | 8.1% | 6.6% | 14.1% | - | - | - |
| EBITDA (USD) | 66,785,000 | 84,298,000 | 118,290,000 | 147,956,000 | 104,653,000 | 158,861,000 | 223,618,000 | - | - | - |
| Operating Income (USD) | 53,826,000 | 58,030,000 | 89,240,000 | 119,266,000 | 56,481,000 | 80,550,000 | 154,084,000 | - | - | - |
| Operating Margin | 14.4% | 13.2% | 16.7% | 20.7% | 9.1% | 12.1% | 20.4% | - | - | - |
| % EBITDA Margin | 17.9% | 19.2% | 22.2% | 25.7% | 16.8% | 24.0% | 29.6% | - | - | - |
| NET Income (USD) | 19,215,000 | 36,091,000 | 63,259,000 | 72,430,000 | 23,982,000 | 33,054,000 | 94,496,000 | - | - | - |
| % Net Margin | 5.2% | 8.2% | 11.9% | 12.6% | 3.9% | 5.0% | 12.5% | - | - | - |
Ceva Santé Animale - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Secondary Buyout | Completed | Ceva Santé Animale | - | ||||||||
| Private Debt | Completed | Ceva Santé Animale | - | ||||||||
| Add-on, Trade Sale | Completed | Scout Bio, Inc. | - | ||||||||
| Joint Venture, LP Direct | Completed | Ceva Bussan Animal Health K.K. | - | ||||||||
| Secondary Buyout | Completed | Ceva Santé Animale | - |
Displaying 1 - 5 of 17
Ceva Santé Animale - employee data
Ceva Santé Animale - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Chairman of the Board | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.